Viewing StudyNCT05165433



Ignite Creation Date: 2024-05-06 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05165433
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-08-02
First Post: 2021-12-07

Brief Title: Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours FORTIFY
Sponsor: Akamis Bio
Organization: Akamis Bio

Conditions & Keywords Data

Conditions:
Name
Metastatic Cancer
Epithelial Tumor
Keywords:
Name View
NG-350A View
Pembrolizumab View
Akamis Bio Ltd View
PsiOxus View
Merck View